D-0021-2022 Class II Terminated
FDA drug recall D-0021-2022 was initiated by Teva Pharmaceuticals USA on Sep 22, 2021 and is designated Class II. Reason for recall: Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol The recall status is terminated (terminated Feb 16, 2023). Affected quantity: 10,665 inhalers.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 27, 2021
- Initiation Date
- Sep 22, 2021
- Termination Date
- Feb 16, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 10,665 inhalers
Product description
AirDuo Digihaler 113/14 (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder, Sample Not For Sale, Rx Only, Mktd by: Teva Respiratory, LLC , Frazer, PA 19355, Manufactured in Ireland, NDC 59310-520-08
Reason for recall
Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol
Distribution pattern
USA Nationwide
Code information
AFR17A
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0021-2022
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026